Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (CopaxoneR)-Reference-Cited by-同舟云学术

Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (CopaxoneR)

Published:2005-06 Issue:6 Volume:12 Page:425-431
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Haas J.,Firzlaff M.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1468-1331.2005.00936.x/fullpdf

Reference18 articles.

1. A Comparison of Observational Studies and Randomized, Controlled Trials

2. Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs

3. Axonal damage in acute multiple sclerosis lesions

4. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do efficacy results obtained from randomized controlled trials translate to effectiveness data from observational studies for relapsing–remitting multiple sclerosis?;Pharmacoepidemiology and Drug Safety;2024-05

2. Adherence to treatment in the management of patients with multiple sclerosis;S.S. Korsakov Journal of Neurology and Psychiatry;2024

3. Beliefs about Medicines and the Level of Intentional Non-Adherence to Treatment among Patients with Multiple Sclerosis Treated with First-Line Drugs;Journal of Clinical Medicine;2023-12-28

4. Ten decadal advances in fungal biology leading towards human well-being;Fungal Diversity;2022-09

5. An Immunomodulatory Peptide Dendrimer Inspired from Glatiramer Acetate;Angewandte Chemie International Edition;2021-11-05